listing plans and opt for Hong Kong instead, with one source at the time citing Beijing's concerns that U.S.
regulators will potentially gain more access to audit documents of New York-listed Chinese companies. read moreĪnalysts also note the tougher stance coincides with new U.S. regulations being rolled out that could see Chinese companies delisted if they do not comply with U.S. auditing rules.Read more: Didi Hit With U.S. LinkDoc’s IPO delay also comes as regulators in Beijing are planning rule changes that would allow them to block a Chinese company from listing overseas even if the unit selling shares is incorporated outside China, closing a loophole long-used by the country’s technology giants, Bloomberg News reported this week. Reuters reported LinkDoc’s IPO halt earlier Thursday.
A representative for LinkDoc declined to comment. LinkDoc, founded in 2014, provides cancer focused health-care services built on big data and artificial intelligence, its website shows. Its investors include Alibaba Health Information Technology Ltd., MBK Partners, New Enterprise Associates and Temasek Holdings Pte according to a preliminary filing.Ĭhinese companies have raised about $13 billion through first-time share sales in the U.S. This case examines a universal question: How can a tech startup (such as an AI or big data startup) address the pain points of traditional vertical industries through technological innovation and create value? Some tech startups set ambitious goals, which demand significant and sustained investments in R&D, but fail to plan for commercial development in order to remain viable: when funding runs out, they go bust.This year, according to data compiled by Bloomberg. Explore Chinabased-companies profile at Times of India for photos, videos and latest news of Chinabased-companies. Others aim for low-hanging fruit in more easily accessible markets, at the expense of pursuing their original goal once engaged on this path, it is extremely difficult to change course and build an iconic name. The LinkDoc Technology (hereinafter 'LinkDoc') case was compiled as one way to find answers to these questions. Medical data group LinkDoc Technology Ltd in July became the first Chinese company to shelve plans for an IPO in the United States due to Beijings clampdown on overseas listings by domestic firms. The issue, then, is how tech startups should strike a balance between "aiming too high" and "taking a faster route." The LinkDoc Technology (hereinafter "LinkDoc") case was compiled as one way to find answers to these questions. Chinese fitness app Keep, podcasting platform Ximalaya, medical solution provider LinkDoc reportedly canceled their US IPO plans after Didi debacle.Details: Keep did not go ahead with its planned public filing while its bankers at Morgan Stanley canceled marketing meetings with investors this week, Financial Times reported, citing people familiar with the matter.
The case examines how LinkDoc, specializing in big data and serving the vertical healthcare industry, found its own answers to these issues and, more specifically, how it identified and entered its target market segment, and.
0 kommentar(er)
